Angel Lucio

CEO @ Tetraneuron | Biotech | Gene therapy | Neuroscience | Seed investor | Termeer Fellow

📍 Spain🔄 Updated September 2026💼 3 investments📅 6 years investing🗓 Last invested Sep 2021
VC🌍 Spain
3
Total investments
1
Early stage
1
Mid stage
1
Late stage
6y
Years active

Portfolio

3 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Seed Investor
Sep 2021
Our mission is simple; we want you to feel Super. We develop science-backed natural supplements to transform your wellbeing by combating stress and its symptoms.
Seed Investor
Jun 2021
Idoven is a health technology company advancing early detection and precision medicine for cardiovascular diseases. The Idoven AI-powered platform delivers substantial improvements to the speed, consistency and accuracy of electrocardiogram (ECG) interpretation. Its powerful, proprietary AI algorithms, which work with existing ECG devices, are also being applied to develop disease biomarkers towards patient identification, risk stratification and prognosis, as well as drug cardiac safety monitoring. Idoven partners with leading medical device and pharmaceutical companies on AI-driven innovations to develop a new standard of cardiovascular care. Through exclusive partnerships and research collaborations, Idoven has developed one of the world’s largest ECG databases and a deep learning system applied to cardiology. The Idoven software is designed to be integrated seamlessly into existing clinical and research workflows, to support clinician decision making and disease management. Idoven has been awarded with numerous distinctions for its AI technology in Europe and the US, including the prestigious European Innovation Council (EIC) Accelerator and Horizon 2020 (H2020) awards and the Healthy Longevity Catalyst Award from the US National Academy of Medicine. The company is backed by top tier investors including Insight Partners, Northzone and Wayra (Telefónica), the Accel Starters programme, leading business angels and EIT Health. Idoven is based in Madrid and was founded in 2018, following almost a decade of ground-breaking research. We are building the future of cardiovascular care, and we need the best minds from around the world to help us. Interested in joining our team? Head to our careers page and apply at www.idoven.ai/jobs
Board Member and Seed Investor
Mar 2020
Tetraneuron is a drug discovery company, focused on the development of a disruptive gene therapy for Alzheimer’s Disease (AD) and an Early Biomarker for this neurodegenerative condition.
Experience · 7 entries
All (7)
Investments (3)
Board (1)
2021
Seed Investor
Sep 2021
Our mission is simple; we want you to feel Super. We develop science-backed natural supplements to transform your wellbeing by combating stress and its symptoms.
Seed Investor
Jun 2021
Idoven is a health technology company advancing early detection and precision medicine for cardiovascular diseases. The Idoven AI-powered platform delivers substantial improvements to the speed, consistency and accuracy of electrocardiogram (ECG) interpretation. Its powerful, proprietary AI algorithms, which work with existing ECG devices, are also being applied to develop disease biomarkers towards patient identification, risk stratification and prognosis, as well as drug cardiac safety monitoring. Idoven partners with leading medical device and pharmaceutical companies on AI-driven innovations to develop a new standard of cardiovascular care. Through exclusive partnerships and research collaborations, Idoven has developed one of the world’s largest ECG databases and a deep learning system applied to cardiology. The Idoven software is designed to be integrated seamlessly into existing clinical and research workflows, to support clinician decision making and disease management. Idoven has been awarded with numerous distinctions for its AI technology in Europe and the US, including the prestigious European Innovation Council (EIC) Accelerator and Horizon 2020 (H2020) awards and the Healthy Longevity Catalyst Award from the US National Academy of Medicine. The company is backed by top tier investors including Insight Partners, Northzone and Wayra (Telefónica), the Accel Starters programme, leading business angels and EIT Health. Idoven is based in Madrid and was founded in 2018, following almost a decade of ground-breaking research. We are building the future of cardiovascular care, and we need the best minds from around the world to help us. Interested in joining our team? Head to our careers page and apply at www.idoven.ai/jobs
2020
Board Member and Seed Investor
Mar 2020
Tetraneuron is a drug discovery company, focused on the development of a disruptive gene therapy for Alzheimer’s Disease (AD) and an Early Biomarker for this neurodegenerative condition.
2017
Associate Director Portfolio Management Takeda Switzerland
Dec 2017
We strive to transform lives. While the science we advance is constantly evolving, our core purpose is enduring. For more than two centuries, our values have guided us to do what’s right for patients and for society. We know that changing lives requires us to do things differently. We start by listening to and addressing what really matters to patients, the people who love them, and those in the healthcare system who provide care. And that’s what inspires us all to be bold, push boundaries and set new standards that open up greater opportunities. Read our community guidelines: https://takeda.info/communityguidelines
2012
Senior M&A Analyst - Asia & Africa
Oct 2012
iNova Pharmaceuticals develops and markets a range of over-the-counter and prescription medicines to Australasia, Asia-Pacific, South Africa and other international markets. Our focus is to improve human health and well-being by providing valued pharmaceutical products and services to patients and consumers. Our product portfolio includes weight management, pain management, dermatology, cardiology, respiratory health and allergy. At iNova our purpose is simple: deliver quality products to our patients, consumers and customers. We have a diverse portfolio of iconic brands, and dedicated employees who put peoples health first across 20 countries including Australia & New Zealand, Asia Pacific and South Africa. With a renewed vision, and an energetic and passionate focus, we are a little bit different and proud of what we do. We want you to join us in our pursuit of healthy living. Our employees work in a wide range of fast-paced, exciting environments - environments that offer continued learning, independence and great opportunities. These opportunities span across Sales and Marketing, Supply Chain, Finance, Technical Operations, IT, HR and Regulatory and Medical Affairs. iNova offers competitive market compensation and benefits. We offer a flexible working environment. And we offer unique opportunities for rewarding and challenging careers. iNova is an Equal Opportunity employer. Were committed to hiring people without discrimination and were always looking for aspirational employees who are motivated to excel, and who are committed to working in a fast-growing, forward-thinking company.
Show all 7 entries ↓
Investment activity
2020–2021 · 3 investments
2020120212
Recent (last 2 years)Earlier